News

Cedars-Sinai joins $31M investment for firm aiming to treat muscular dystrophy, cancer | Health IT

By October 18, 2022No Comments

Los Angeles-based Cedars-Sinai joined a $31 million funding round for Vita Therapeutics, a company that uses genetics to develop new cellular therapies to treat muscular dystrophy and cancer.Health IT

Leave a Reply Cancel Reply

The Washington Metropolitan Area Chapter(WMAC) of the National Association of Health Services Executives (NAHSE) was chartered in 1978 to educate and develop minority healthcare leaders while, in conjunction with the American College of Healthcare Executives (ACHE), promoting C-Suite diversity for Healthcare Organizations throughout Northern Virginia, Southern Maryland, and the District of Columbia. The Washington Metropolitan Area Chapter (WMAC) was one of the first two chapters founded by the Association, since its inception.

Cedars-Sinai joins $31M investment for firm aiming to treat muscular dystrophy, cancer | Health IT

Tags:

Previous PostCIOs make cybersecurity top investment as threats rise | Health IT

Next PostSome CommonSpirit affiliates in the process of restoring IT systems | Health IT

Leave a Reply Cancel Reply

Join the NAHSE-WMAC Mailing List

Contact Us